Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Myeloid, Acute 7Lymphoma 5Leukemia 5Lymphoma, Non-Hodgkin 4Leukemia, Biphenotypic, Acute 4Squamous Cell Carcinoma of Head and Neck 3Myelodysplastic Syndromes 3Multiple Myeloma 3Head and Neck Neoplasms 3Stomach Neoplasms 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Mantle-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, B-Cell 2Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 2Anemia, Refractory, with Excess of Blasts 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm, Residual 1Lymphoma, T-Cell, Cutaneous 1

Interventions

pembrolizumab 7fludarabine 3Cyclophosphamide 3motexafin gadolinium 1fludarabine phosphate 1durvalumab 1Taxes 1Pemetrexed 1Paclitaxel 1Nivolumab 1MEDI0457 1Drug Therapy 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Oropharyngeal Neoplasms × fludarabine phosphate × Clear all
NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc.

Phase 1 Not yet recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡